STO-609
Product Specifications
UNSPSC Description
STO-609 is a selective and cell-permeable inhibitor of the Ca2+/calmodulin-dependent protein kinase kinase (CaM-KK), with Ki values of 80 and 15 ng/mL for recombinant CaM-KKα and CaM-KKβ, respectively. STO-609 inhibits AMP-activated protein kinase kinase (AMPKK) activity in HeLa cell lysates with an IC50 ~0.02 g/ml.
Target Antigen
AMPK; Autophagy; CaMK
Type
Reference compound
Related Pathways
Autophagy;Epigenetics;Neuronal Signaling;PI3K/Akt/mTOR
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/STO-609.html
Purity
98.13
Smiles
O=C(C1=C2C3=C(C4=NC5=CC=CC=C5N4C(C3=CC=C2)=O)C=C1)O
Molecular Weight
314.29
References & Citations
[1]Tokumitsu H, et al. STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase. J Biol Chem. 2002 May 3;277(18):15813-8.|[2]Kukimoto-Niino M, et al. Crystal structure of the Ca<sup>2+</sup>/calmodulin-dependent protein kinase kinase in complex with the inhibitor STO-609. J Biol Chem. 2011 Jun 24;286(25):22570-9.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-19805/STO-609-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-19805/STO-609-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
52029-86-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6214671-01 0.1 mL
UGT2B4 (UGT2B11, UDP-glucuronosyltransferase 2B4, UDPGT 2B4, HLUG25, Hyodeoxycholic Acid-specific UDPGT, UDPGTh-1) (MaxLight 550)
Ask
View Details MBS6214671-02 5x 0.1 mL
UGT2B4 (UGT2B11, UDP-glucuronosyltransferase 2B4, UDPGT 2B4, HLUG25, Hyodeoxycholic Acid-specific UDPGT, UDPGTh-1) (MaxLight 550)
Ask
View Details